Comparison Overview

SpringWorks Therapeutics

VS

The National Institutes of Health

SpringWorks Therapeutics

100 Washington Blvd, Stamford, Connecticut, 06902, US
Last Update: 2025-03-05 (UTC)
Between 750 and 799

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors and hematological cancers, including clinical trials in rare tumor types and highly prevalent, genetically defined cancers.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 388
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

The National Institutes of Health

9000 Rockville Pike, Bethesda, MD, 20892, US
Last Update: 2025-03-04 (UTC)
Between 750 and 799

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 30,993
Subsidiaries: 50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/springworks-therapeutics.jpeg
SpringWorks Therapeutics
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/national-institutes-of-health.jpeg
The National Institutes of Health
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
SpringWorks Therapeutics
100%
Compliance Rate
0/4 Standards Verified
The National Institutes of Health
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for SpringWorks Therapeutics in 2025.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for The National Institutes of Health in 2025.

Incident History — SpringWorks Therapeutics (X = Date, Y = Severity)

SpringWorks Therapeutics cyber incidents detection timeline including parent company and subsidiaries

Incident History — The National Institutes of Health (X = Date, Y = Severity)

The National Institutes of Health cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/springworks-therapeutics.jpeg
SpringWorks Therapeutics
Incidents

No Incident

https://images.rankiteo.com/companyimages/national-institutes-of-health.jpeg
The National Institutes of Health
Incidents

No Incident

FAQ

The National Institutes of Health company demonstrates a stronger AI Cybersecurity Score compared to SpringWorks Therapeutics company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, The National Institutes of Health company has disclosed a higher number of cyber incidents compared to SpringWorks Therapeutics company.

In the current year, The National Institutes of Health company and SpringWorks Therapeutics company have not reported any cyber incidents.

Neither The National Institutes of Health company nor SpringWorks Therapeutics company has reported experiencing a ransomware attack publicly.

Neither The National Institutes of Health company nor SpringWorks Therapeutics company has reported experiencing a data breach publicly.

Neither The National Institutes of Health company nor SpringWorks Therapeutics company has reported experiencing targeted cyberattacks publicly.

Neither SpringWorks Therapeutics company nor The National Institutes of Health company has reported experiencing or disclosing vulnerabilities publicly.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds any compliance certifications.

Neither company holds any compliance certifications.

The National Institutes of Health company has more subsidiaries worldwide compared to SpringWorks Therapeutics company.

The National Institutes of Health company employs more people globally than SpringWorks Therapeutics company, reflecting its scale as a Biotechnology Research.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds SOC 2 Type 1 certification.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds SOC 2 Type 2 certification.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds ISO 27001 certification.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds PCI DSS certification.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds HIPAA certification.

Neither SpringWorks Therapeutics nor The National Institutes of Health holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X